Pharmalive -- Brisbane (Australia) and Honolulu (Hawaii), September 1, 2008-Avantogen Ltd (ASX: ACU) is pleased to announce additional support for the Dengue vaccine program developed by Hawaii Biotech Inc, in which Avantogen holds a significant investment stake.
